Calcified Tissue International

, Volume 86, Issue 6, pp 502–510 | Cite as

Administration of the Bisphosphonate Zoledronic Acid During Tooth Development Inhibits Tooth Eruption and Formation and Induces Dental Abnormalities in Rats

  • Toru Hiraga
  • Tadashi Ninomiya
  • Akihiro Hosoya
  • Hiroaki Nakamura


Bisphosphonates (BPs) are potent inhibitors of osteoclastic bone resorption and widely used for the treatment of osteoporosis and metastatic bone diseases. Recently, BPs have also been shown to benefit children with primary and secondary osteoporosis, including osteogenesis imperfecta; however, their long-term safety has not been established yet. Clinical and experimental studies have demonstrated that BPs delay or inhibit tooth eruption. The failure of tooth eruption causes several dental abnormalities. In this study, to determine the effects of BPs on tooth formation, the BP zoledronic acid (ZOL) was injected into 7- and 14-day-old rats, and the development of the mandibular teeth was examined. X-ray analysis demonstrated that ZOL inhibited the eruption of both incisors and molars and their formation, especially in the molar roots. Histological examination showed that, in ZOL-treated animals, alveolar bone remained unresorbed around tooth crowns, which injured ameloblasts and enamel matrix, leading to defects of the enamel. Furthermore, haphazard proliferation of odontogenic epithelium and mesenchyme associated with primitive tooth structures, which resembles human odontomas, was induced at the basal end of incisors but not around the molars. Tooth ankylosis to alveolar bone was occasionally observed in molars. These results suggest that administration of BPs during tooth development has the potential to inhibit tooth eruption and formation and to induce several types of dental abnormalities, which may be attributed to the altered osteoclastic activities.


Bisphosphonate Zoledronic acid Tooth eruption Dental abnormality Odontoma 


  1. 1.
    Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032–1045CrossRefPubMedGoogle Scholar
  2. 2.
    Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209–257CrossRefPubMedGoogle Scholar
  3. 3.
    Castillo H, Samson-Fang L (2009) Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol 51:17–29CrossRefPubMedGoogle Scholar
  4. 4.
    Bachrach L, Ward L (2009) Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 94:400–409CrossRefPubMedGoogle Scholar
  5. 5.
    Shaw NJ (2008) Management of osteoporosis in children. Eur J Endocrinol 159 Suppl 1:S33–S39CrossRefPubMedGoogle Scholar
  6. 6.
    ElNesr NM, Avery JK (2002) Tooth eruption and shedding. In: Avery JK (ed) Oral development and histology. Thieme, New York, pp 123–140Google Scholar
  7. 7.
    Wise G, King G (2008) Mechanisms of tooth eruption and orthodontic tooth movement. J Dent Res 87:414–434CrossRefPubMedGoogle Scholar
  8. 8.
    Kamoun-Goldrat A, Ginisty D, Le Merrer M (2008) Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 116:195–198CrossRefPubMedGoogle Scholar
  9. 9.
    Hodgson B (2009) More about bisphosphonates. J Am Dent Assoc 140:829–830PubMedGoogle Scholar
  10. 10.
    Bradaschia-Correa V, Massa L, Arana-Chavez V (2007) Effects of alendronate on tooth eruption and molar root formation in young growing rats. Cell Tissue Res 330:475–485CrossRefPubMedGoogle Scholar
  11. 11.
    Grier RT, Wise G (1998) Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res 77:8–15CrossRefPubMedGoogle Scholar
  12. 12.
    Helfrich M (2005) Osteoclast diseases and dental abnormalities. Arch Oral Biol 50:115–122CrossRefPubMedGoogle Scholar
  13. 13.
    Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702CrossRefPubMedGoogle Scholar
  14. 14.
    Ida-Yonemochi H, Noda T, Shimokawa H, Saku T (2002) Disturbed tooth eruption in osteopetrotic (op/op) mice: histopathogenesis of tooth malformation and odontomas. J Oral Pathol Med 31:361–373CrossRefPubMedGoogle Scholar
  15. 15.
    Amling M, Neff L, Priemel M, Schilling A, Rueger J, Baron R (2000) Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone 27:603–610CrossRefPubMedGoogle Scholar
  16. 16.
    Tiffee J, Xing L, Nilsson S, Boyce B (1999) Dental abnormalities associated with failure of tooth eruption in src knockout and op/op mice. Calcif Tissue Int 65:53–58CrossRefPubMedGoogle Scholar
  17. 17.
    Kawata T, Tokimasa C, Nowroozi N, Fujita T, Kaku M, Kawasoko S, Sugiyama H, Ozawa S, Zernik J, Tanne K (1999) Lack of the bone remodeling in osteopetrotic (op/op) mice associated with microdontia. J Craniofac Genet Dev Biol 19:113–117PubMedGoogle Scholar
  18. 18.
    Hiraga T, Nakamura H (2009) Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals. Int J Cancer 124:215–222CrossRefPubMedGoogle Scholar
  19. 19.
    Irie K, Ozawa H (1990) Relationships between tooth eruption, occlusion and alveolar bone resorption: cytological and cytochemical studies of bone resorption on rat incisor alveolar bone facing the enamel. Arch Histol Cytol 53:497–509CrossRefPubMedGoogle Scholar
  20. 20.
    Inage T, Shimokawa H, Teranishi Y, Iwase T, Toda Y, Moro I (1989) Immunocytochemical demonstration of amelogenins and enamelins secreted by ameloblasts during the secretory and maturation stages. Arch Histol Cytol 52:213–229CrossRefPubMedGoogle Scholar
  21. 21.
    Mori M, Yamada K, Kasai T, Yamada T, Shimokawa H, Sasaki S (1991) Immunohistochemical expression of amelogenins in odontogenic epithelial tumours and cysts. Virchows Arch A Pathol Anat Histopathol 418:319–325CrossRefPubMedGoogle Scholar
  22. 22.
    Fujita S, Hideshima K, Ikeda T (2006) Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours. J Clin Pathol 59:240–245CrossRefPubMedGoogle Scholar
  23. 23.
    Miyazaki T, Kanatani N, Rokutanda S, Yoshida C, Toyosawa S, Nakamura R, Takada S, Komori T (2008) Inhibition of the terminal differentiation of odontoblasts and their transdifferentiation into osteoblasts in Runx2 transgenic mice. Arch Histol Cytol 71:131–146CrossRefPubMedGoogle Scholar
  24. 24.
    Chahine C, Cheung M, Head T, Schwartz S, Glorieux F, Rauch F (2008) Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 153:719–720CrossRefPubMedGoogle Scholar
  25. 25.
    Malmgren B, Aström E, Söderhäll S (2008) No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med 37:196–200PubMedCrossRefGoogle Scholar
  26. 26.
    Schwartz S, Joseph C, Iera D, Vu D (2008) Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series. J Can Dent Assoc 74:537–542PubMedGoogle Scholar
  27. 27.
    Kostenuik P (2009) Inhibition of bone resorption by OPG or alendronate significantly reduced bone growth, molar eruption and tooth root development in neonatal rats. Bone 45:S50CrossRefGoogle Scholar
  28. 28.
    Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269–272CrossRefPubMedGoogle Scholar
  29. 29.
    Wise GE, Fan W (1989) Changes in the tartrate-resistant acid phosphatase cell population in dental follicles and bony crypts of rat molars during tooth eruption. J Dent Res 68:150–156PubMedGoogle Scholar
  30. 30.
    Tiwana P, Kushner G (2005) Management of impacted teeth in children. Oral Maxillofac Surg Clin North Am 17:365–373CrossRefPubMedGoogle Scholar
  31. 31.
    Younai F, Eisenbud L, Sciubba J (1988) Osteopetrosis: a case report including gross and microscopic findings in the mandible at autopsy. Oral Surg Oral Med Oral Pathol 65:214–221CrossRefPubMedGoogle Scholar
  32. 32.
    Schenk R, Merz WA, Muhlbauer R, Russell RG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196–214CrossRefPubMedGoogle Scholar
  33. 33.
    Sakai H, Takano Y, Ohya K, Kurosaki N (1999) Intermittent inhibition of dentin mineralization of rat incisors under continual infusion of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) using a subcutaneous mini osmotic pump. Arch Histol Cytol 62:171–179CrossRefPubMedGoogle Scholar
  34. 34.
    Yamada Y, Fuangtharnthip P, Tamura Y, Takagi Y, Ohya K (2000) Gene expression and immunolocalization of amelogenin in enamel hypoplasia induced by successive injections of bisphosphonate in rat incisors. Arch Oral Biol 45:207–215CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Toru Hiraga
    • 1
  • Tadashi Ninomiya
    • 2
  • Akihiro Hosoya
    • 1
  • Hiroaki Nakamura
    • 1
  1. 1.Department of Histology and Cell BiologyMatsumoto Dental UniversityShiojiriJapan
  2. 2.Division of Hard Tissue Research, Institute for Oral ScienceMatsumoto Dental UniversityShiojiriJapan

Personalised recommendations